Details of the Drug Reposition

General Information of This Drug (ID: DM79GPF)

Drug Name
CD19.CAR T Cells   DM79GPF
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1/2 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 1/2 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03676504) Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR